up to now few years, the UK has witnessed a revolution in clinical body weight‑decline therapies — from your introduction of semaglutide (Wegovy®) into the expanding acceptance of tirzepatide (Mounjaro®). Now, another title is drawing interest in both scientific and public wellbeing circles: Reta